Bajaj Healthcare

BAJAJHCARE26 Apr 2024

Pharmaceuticals

₹

-1.10 (-0.33%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Bajaj Healthcare

Bajaj Healthcare

Pharmaceuticals

BAJAJHCARE26 Apr 2024

₹

-1.10 (-0.33%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
13-Aug-2021	S	The Board of Directors at its Meeting held today has inter alia: Recommended the proposal for sub-division of Company's One (1) equity share of face value of Rs 10/- each into Two (2) equity shares of face value of Rs.05/- each, subject to the shareholders and other approvals as may be required. Recommended alteration of Capital Clause (Clause V) in the Memorandum of Association of the Company, subject to the approval of shareholders The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9' September, 2015, ('SEBI Circular') have been enclosed herewith as 'Annexure -I' for sub-division and alteration of capital cause of Memorandum of Association. Trading Members of the Exchange are hereby informed that BAJAJ HEALTHCARE LTD. has fixed the Record Date for the purpose of sub division of equity shares of the company: DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE BAJAJ HEALTHCARE LTD. (539872) RECORD DATE 29/09/2021 PURPOSE (1) Sub Division of existing equity shares from every One equity share of Rs. 10/- each into Two equity shares of Rs. 5/- each. and (2) Final Dividend of Re.0.50 (5%) per share SUB-DIVIDED PAID-UP VALUE Rs.5/- SUB-DIVIDED PAID-UP VALUE W.E.F. 28/09/2021 DR-124/2021-2022 Note:- i. ISIN No. INE411U01019 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 28/09/2021. ii. The new ISIN Number for Rs.5/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 20.09.2021) In Continuation of Notice No. 20210920-49 dated September 20, 2021, Trading Members of the Exchange are hereby informed that the New ISIN number for the equity shares of the company will be as under: - Company Name & Scrip Code BAJAJ HEALTHCARE LTD. (539872) New ISIN No. INE411U01027 Remarks Sub-division of equity shares from Rs.10/- to Rs.5/- The new ISIN number given above, for Equity Shares of Rs.5/- each of the company shall be effective for trades done on and from the Ex-Date i.e. 28-09-2021 (DR-124/2021-2022) (As Per BSE Notice Dated on 22.09.2021) Intimation of new ISIN for Fully Paid up Equity Shares with Face value of Rs.5/-. (As Per BSE Announcement dated on 22.09.2021) This is in continuation to our communication dated 22nd September, 2021 with respect to Sub-division of Equity Share of face value of Rs. 10 each fully paid up into Equity Shares of face value of Rs. 5 each fully paid up with effect from 29th September, 2021 (Record Date). Please be informed that the Sub-Division of Equity Shares has taken effect under the new ISIN i.e. INE411U01027. Kindly take the above information on records. (As Per BSE announcement Dated on 01.10.2021)	29-Sep-2021
30-May-2023	D	Outcome of Board Meeting held on 30th May, 2023 & Submission of financial result. Recommended a final dividend of 20% i.e. Re.1.00/- per equity share for the financial year ended 31st March, 2023, subject to approval of shareholders in the ensuing Annual General Meeting. Intimation of record dates for payment of dividend. (As Per BSE Announcement dated on 07.09.2023)	22-Sep-2023
17-May-2022	D	We hereby inform you that at the meeting of the Board of Directors of our Company held today i.e. 17th May, 2022 has considered and approved the following: - The Board of Directors have recommended a final dividend of 30% i.e. Rs.1.50/- per equity shares on face value of Rs.5/- each for the financial year ended 31st March, 2022, subject to approval of shareholders in the ensuing Annual General Meeting. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Friday, September 23, 2022 is fixed as the record date for the purpose of payment of dividend, if approved by the shareholders at the ensuing Annual General Meeting. (As Per BSE Announcement Dated 08.09.2022)	22-Sep-2022
09-Jun-2021	D	Recommended payment of final dividend of Re. 0.50/- and special dividend of Re. 0.50/- per equity share of Rs 10/- each for the year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting The Company has already declared and paid interim dividends of 12.50% ( Rs.1.25 /-) each per share of Rs. 10/- each for the financial year ended 31st March,2021. The total dividend for the financial year ended 31st March 2021(including the special dividend) works out to 27.50% (Rs. 2.75/-) per share of Rs.10 each	28-Sep-2021
09-Jun-2021	D	Recommended payment of final dividend of Re. 0.50/- and special dividend of Re. 0.50/- per equity share of Rs 10/- each for the year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting The Company has already declared and paid interim dividends of 12.50% ( Rs.1.25 /-) each per share of Rs. 10/- each for the financial year ended 31st March,2021. The total dividend for the financial year ended 31st March 2021(including the special dividend) works out to 27.50% (Rs. 2.75/-) per share of Rs.10 each	28-Sep-2021
19-Nov-2020	D	We would like to inform you that at the Board Meeting held today, the Directors have declared Interim Dividend of Rs. 1.25/- and Special Dividend Rs. 0.50/- per equity shares of Rs. 10/- each of the Company. The Interim Dividend and Special Dividend shall be paid on or before December 15, 2020 to the equity shareholders of the Company, whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Tuesday, 1st December, 2020 which is the Record Date fixed for the purpose. We wish to inform you that Board Meeting commenced today at 03.00 p.m. and concluded at 3.20 p.m. Kindly take the same on record.	01-Dec-2020
19-Nov-2020	D	We would like to inform you that at the Board Meeting held today, the Directors have declared Interim Dividend of Rs. 1.25/- and Special Dividend Rs. 0.50/- per equity shares of Rs. 10/- each of the Company. The Interim Dividend and Special Dividend shall be paid on or before December 15, 2020 to the equity shareholders of the Company, whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Tuesday, 1st December, 2020 which is the Record Date fixed for the purpose. We wish to inform you that Board Meeting commenced today at 03.00 p.m. and concluded at 3.20 p.m. Kindly take the same on record.	01-Dec-2020
29-May-2018	D	Bajaj Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2018, inter alia, have declared a divided @ 10% i.e. Rs. 1.00/- per equity shares for the year ended March 31, 2018.	19-Sep-2018
01-Apr-2019	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Bajaj Healthcare Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Bajaj Healthcare Limited (539872) RECORD DATE 10/04/2019 PURPOSE Issue of 1 (One) Bonus equity share of Rs.10/- each for every 1 (One) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 09/04/2019 DR-009/2019-2020 Trading Members of the Exchange are requested to take of it. (As Per BSE Notice Dated on 02.04.2019)	10-Apr-2019	1:1
16-Feb-2024	BC	Namrata Sajankumar Bajaj	15-Feb-2024
03-Feb-2024	BC	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of Securities Ex	09-Feb-2024
09-Feb-2024	BC	Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') this is to inform you that the Board of Directors of our Company at its	09-Feb-2024
03-Feb-2024	BC	Resignation of Mr. Aakashkumar Keshari from the position of Company Secretary & Compliance Officer of the Company w.e.f. 3rd February, 2024.	03-Feb-2024
26-Dec-2023	BC	Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for Resignation of Independent Director.	26-Dec-2023

Announcement Date30-May-2023

Ex Dividend Date22-Sep-2023

Dividend(%)20

Announcement Date17-May-2022

Ex Dividend Date22-Sep-2022

Dividend(%)30

Announcement Date09-Jun-2021

Ex Dividend Date28-Sep-2021

Dividend(%)5

Announcement Date09-Jun-2021

Ex Dividend Date28-Sep-2021

Dividend(%)5

Announcement Date19-Nov-2020

Ex Dividend Date01-Dec-2020

Dividend(%)12

Announcement Date19-Nov-2020

Ex Dividend Date01-Dec-2020

Dividend(%)5

Announcement Date29-May-2018

Ex Dividend Date19-Sep-2018

Dividend(%)10

No Rights has been declared by BAJAJHCARE

Book Closure

Record Date	Split Date	Purpose
15-Feb-2024	-	Namrata Sajankumar Bajaj
09-Feb-2024	-	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of Securities Ex
09-Feb-2024	-	Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') this is to inform you that the Board of Directors of our Company at its
03-Feb-2024	-	Resignation of Mr. Aakashkumar Keshari from the position of Company Secretary & Compliance Officer of the Company w.e.f. 3rd February, 2024.
26-Dec-2023	-	Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for Resignation of Independent Director.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Bajaj Healthcare Ltd ₹327.35(-1.10/-0.33%)	327.35	-1.10	903.43	3.67	31.32	2.85
Lupin Ltd ₹1,615.95(+21.55/1.35%)	1,615.95	+21.55	73,646.94	128.34	35.73	3.82
Ipca Laboratories Ltd ₹1,338.50(+10.05/0.76%)	1,338.50	+10.05	33,958.31	90.83	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,865.05(+2.25/0.12%)	1,865.05	+2.25	28,944.61	77.48	57.14	10.78
Sanofi India Ltd ₹8,274.15(+120.75/1.48%)	8,274.15	+120.75	19,055.37	38.57	32.28	18.77
IOL Chemicals & Pharmaceuticals Ltd ₹399.50(-0.85/-0.21%)	399.50	-0.85	2,345.28	-2.77	13.60	1.48

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	108.57	101.21	129.74	154.11	132.57	195.32
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	108.57	101.21	129.74	154.11	132.57	195.32
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.80	1.22	0.22	0.72	0.07	0.13
Total Income	109.37	102.43	129.95	154.83	132.64	195.45
Total Expenditure	96.76	90.84	163.23	139.65	107.83	165.81
PBIDT	12.61	11.58	-33.28	15.18	24.81	29.65
Interest	6.65	8.26	8.75	5.97	5.37	3.64
PBDT	5.96	3.32	-42.03	9.22	19.44	26.00
Depreciation	7.35	6.66	6.31	4.69	4.43	4.00
Tax	1.36	0.00	0.00	2.29	4.08	5.73
Deferred Tax	-0.56	0.12	-0.12	-1.36	-0.12	-0.09
Reported Profit After Tax	-2.20	-3.46	-48.21	3.59	11.05	16.36
Extra-ordinary Items	-7.72	-8.58	-55.24	-7.56	-5.70	-4.92
Adjusted Profit After Extra-ordinary item	5.52	5.12	7.03	11.15	16.75	21.28

EPS (Unit Curr.)	-0.80	-1.25	-17.47	1.30	4.01	5.93
EPS (Adj) (Unit Curr.)	-0.80	-1.25	-17.47	1.30	4.01	5.93
Calculated EPS (Unit Curr.)	-0.80	-1.25	-17.47	1.30	4.01	5.93
Calculated EPS (Adj) (Unit Curr.)	-0.80	-1.25	-17.47	1.30	4.01	5.93
Calculated EPS (Ann.) (Unit Curr.)	-3.18	-5.02	-69.88	5.21	16.02	23.71
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-3.18	-5.02	-69.88	5.21	16.02	23.71
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	13.80	13.80	13.80	13.80	13.80	13.80
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	5.00	5.00	5.00	5.00	5.00	5.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	11.61	11.44	-25.65	9.85	18.71	15.18
PBDTM(%)	5.49	3.28	-32.40	5.98	14.66	13.31
PATM(%)	-2.03	-3.42	-37.16	2.33	8.34	8.38

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	13.80	13.80	13.80	13.80	6.90	6.90
Reserves Total	353.89	314.69	244.61	164.13	122.21	106.71
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	367.69	328.49	258.41	177.93	129.11	113.61
Secured Loans	413.68	255.13	180.89	90.53	77.33	81.48
Unsecured Loans	1.56	1.60	0.00	0.40	3.40	5.04
Total Debt	415.24	256.73	180.89	90.93	80.73	86.52
Total Liabilities	782.93	585.22	439.30	268.86	209.84	200.13
APPLICATION OF FUNDS :
Gross Block	525.01	401.73	329.25	267.83	222.23	209.65
Less : Accumulated Depreciation	159.32	131.98	121.13	105.59	93.74	83.03
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	365.69	269.75	208.12	162.24	128.49	126.62
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	21.73	51.98	57.05	5.45	1.18	1.97
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	5.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	208.79	159.26	97.11	39.28	30.05	33.66
Sundry Debtors	227.41	184.51	98.88	98.48	78.13	80.38
Cash and Bank	17.72	1.98	14.24	4.16	7.86	8.29
Loans and Advances	55.82	52.56	48.10	26.50	21.13	17.22
Total Current Assets	509.74	398.31	258.33	168.42	137.17	139.55
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	100.89	122.14	81.23	69.75	47.16	58.78
Provisions	14.34	9.51	0.18	0.52	6.84	7.25
Total Current Liabilities	115.24	131.65	81.41	70.27	54.00	66.03
Net Current Assets	394.50	266.66	176.93	98.15	83.17	73.51
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.06	0.59	0.00	0.00	0.00	0.00
Deferred Tax Liability	1.56	2.15	2.15	1.74	1.59	1.20
Net Deferred Tax	-0.50	-1.56	-2.15	-1.74	-1.59	-1.20
Total Assets	781.42	586.82	439.96	269.10	211.26	200.90
Contingent Liabilities	7.24	3.51	10.05	6.42	1.98	8.41

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.98	14.24	4.16	7.86	8.29
Net Cash from Operating Activities	-22.32	0.69	43.56	20.57	25.17
Net Cash Used In Investing Activities	-93.43	-74.80	-108.93	-27.56	-13.03
Net Cash Used In Financing Activities	131.50	61.85	75.46	3.28	-12.57
Net Inc./Dec In Cash And Cash Equivalents	15.75	-12.27	10.08	-3.70	-0.42
Cash And Cash Equivalents At End Of The Year	17.72	1.98	14.24	4.16	7.86

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

67.73%

FII Shareholding

0.53%

DII Shareholding

0.44%

Public Shareholding

31.30%

**Promoter pledged shareholding 67.73%

About Bajaj Healthcare Ltd

Bajaj Healthcare Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 902.47 crores. It has reported a sales of Rs. 108.57 crores and a net profit of Rs. -2.2 crores for the quarter ended December 2018. The company management includes Sanjankumar R Bajaj, Sanjankumar R Bajaj,Anil C Jain,Namrata S Bajaj,Dhananjay S Halte,Ram B Banarase,Hemant R Karnik,Aakashkumar Kesari,Loukik D Tipnis,Kejal Shah,Pakshal Jain,Rupesh H Nikam (Bajaj Healthcare Ltd) among others.

Chairman

Sanjankumar R Bajaj

Registered office

602-606 Bhoomi Velocity Infote,Road No 23 Wagle Indl Estate,Thane,Maharashtra,400604

FAX :91-22-66177458

Background

Incorporation Year1993

Face Value₹5

Market Lot1

How to buy Bajaj Healthcare shares on nse?

To buy Bajaj Healthcare shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Bajaj Healthcare share price today?

The Bajaj Healthcare shares price on nse is Rs.327.35 today.

What is the market cap of Bajaj Healthcare shares on NSE ?

The company has a market capitalization of Rs.903.43Cr

What is the PE & PB ratio of Bajaj Healthcare shares ?

PE is 31.32 and PB is 2.85

What is the 52 Week High and Low of Bajaj Healthcare shares?

Bajaj Healthcare stock price high: Rs.513.4 Bajaj Healthcare stock price low: Rs.275.7